Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity

Pedro Melgar-Lesmes, Fernando Garcia-Polite, Paula Del-Rey-Puech, Elisabet Rosas, Juliana L. Dreyfuss, Eulàlia Montell, Josep Vergés, Elazer R. Edelman, Mercedes Balcells

Producción científica: Artículo en revista indizadaArtículorevisión exhaustiva

39 Citas (Scopus)


Background and aims: Osteoarthritic patients treated with high doses of chondroitin sulfate (CS) have a lower incidence of coronary heart disease - but the mechanistic aspects of these beneficial effects of CS remain undefined. We examined how CS treatment affects the formation of atheroma via interaction with endothelial cells and monocytes. Methods: We characterized arterial atheromatous plaques by multiphoton microscopy and serum pro-inflammatory cytokines by immunoenzymatic techniques in obese mice receiving CS (1 g/kg/day, i.p.) or vehicle for 6 days. Effects of CS on signaling pathways, cytokine secretion and macrophage migration were evaluated in cultures of human coronary endothelial cells and in a monocyte cell line stimulated with TNF-α by Western blot, immunoenzymatic techniques and transwell migration assays. Results: Treatment of obese mice with CS reduced the extension of foam cell coverage in atheromatous plaques of arterial bifurcations by 62.5%, the serum concentration of IL1β by 70%, TNF-α by 82% and selected chemokines by 25-35%. Cultures of coronary endothelial cells and monocytes stimulated with TNF-α secreted less pro-inflammatory cytokines in the presence of CS (P < 0.01). CS reduced the activation of the TNF-α signaling pathway in endothelial cells (pErk 36% of reduction, and NFκB 33% of reduction), and the migration of activated monocytes to inflamed endothelial cells in transwells (81 ± 6 vs. 13 ± 2, P < 0.001). Conclusions: CS interferes with the pro-inflammatory activation of monocytes and endothelial cells driven by TNF-α thus reducing the propagation of inflammation and preventing the formation of atherosclerotic plaques.

Idioma originalInglés
Páginas (desde-hasta)82-87
Número de páginas6
EstadoPublicada - 1 feb 2016


Profundice en los temas de investigación de 'Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity'. En conjunto forman una huella única.

Citar esto